This large , multicenter , simulated-use study evaluated whether adults ( aged 18-65 years ) , caregivers ( parents/guardians aged 18-65 years of children aged 5-17 years ) , and children ( aged 11-17 years ) , with and without experience in using an EAI , had a preference for the current design of Auvi-Q or the current design of EpiPen .